These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 37560311)

  • 1. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.
    Masse KE; Lu VB
    Front Endocrinol (Lausanne); 2023; 14():1169624. PubMed ID: 37560311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial metabolites as modulators of host physiology.
    Joyce SA; Clarke DJ
    Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
    Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of microbially derived short-chain fatty acids on intestinal homeostasis, metabolism, and neuropsychiatric disorder.
    Xiao S; Jiang S; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):589-601. PubMed ID: 31865438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial fermentation of flaxseed fibers modulates the transcriptome of GPR41-expressing enteroendocrine cells and protects mice against diet-induced obesity.
    Arora T; Rudenko O; Egerod KL; Husted AS; Kovatcheva-Datchary P; Akrami R; Kristensen M; Schwartz TW; Bäckhed F
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E453-E463. PubMed ID: 30562060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential mediators linking gut bacteria to metabolic health: a critical view.
    Janssen AW; Kersten S
    J Physiol; 2017 Jan; 595(2):477-487. PubMed ID: 27418465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles.
    Abdul Rahim MBH; Chilloux J; Martinez-Gili L; Neves AL; Myridakis A; Gooderham N; Dumas ME
    Acta Diabetol; 2019 May; 56(5):493-500. PubMed ID: 30903435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
    Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
    Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota, enteroendocrine functions and metabolism.
    Cani PD; Everard A; Duparc T
    Curr Opin Pharmacol; 2013 Dec; 13(6):935-40. PubMed ID: 24075718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases.
    Fogelson KA; Dorrestein PC; Zarrinpar A; Knight R
    Gastroenterology; 2023 Jun; 164(7):1069-1085. PubMed ID: 36841488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
    Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
    Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.